edisylate

[ĕ-dis´ĭ-lāt]

USAN contraction for 1,2-ethanedisulfonate.

e·dis·y·late

(e-dis'i-lāt),

USAN-approved contraction for 1,2-ethanedisulfonate, ^-O₃S(CH₂)₂SO₃^-.

edisylate

/edis·y·late/ (ĕ-dis´ĭ-lāt) USAN contraction for 1,2-ethanedisulfonate.

Mentioned in ?

References in periodicals archive ?

Heritage") announced the immediate availability of Prochlorperazine Edisylate Injection in the 5mg/mL strength.

Prochlorperazine Edisylate Injection is indicated for the treatment of severe nausea and vomiting.

Heritage Pharma Announces The Launch Of Prochlorperazine Injection

has received approval of an Abbreviated New Drug Application (ANDA) from the Food and Drug Administration (FDA) for Prochlorperazine Edisylate Injection.

Gensia Sicor's version of prochlorperazine edisylate injection will be available in two presentations: a 5mg/mL 2mL vial and a 5mg/mL 10mL vial.